BriggsJAG. Vomiting in pregnancy. Causes and management. Drugs1975; 9: 299–306.
2.
MilkovichLVan Den BergBJ. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstel Gynecol1976; 125: 244–8.
3.
KullanderSKallenB. A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand1976; 55: 105–11.
4.
RunnerMN. Symposium on 25 years of progress in mammalian genetics and cancer; inheritance of susceptibility to congenital deformity—embryonic instability. J Natl Cancer Inst1954; 15: 637.
5.
RunnerMNMillerJR. Congenital deformity in the mouse as a consequence of fasting (abstract). Anal Rec1956; 124: 437.
6.
RosenzweigSBlausteinFM. Cleft palate in A/J mice resulting from restraint and deprivation of food and water. Teratology1971; 3: 47–51.
7.
WarkanyJPeteringH. Congenital malformations of the brain produced by short zinc deficiencies in rats. Am J Ment Defic1973; 77: 645–53.
8.
HaysDP. Teratogenesis: a review of the basic principles with a discussion of selected agents: parts I and II. Drug Intell Clin Pharm1981; 15: 444–58, 542–66.
9.
McBrideWG. An etiological study of drug ingestion by women who give birth to babies with cleft palate. Aust NZ J Obstet Gynecol1969; 9: 103–7.
10.
MidwinterA. Vomiting in pregnancy. Practitioner1971; 206: 743–50.
11.
CheckWA. CDC study: no evidence for teratogenicitv of Bendectin (news). JAMA1979; 242: 2518.
12.
AMA Department of Drugs. Drugs used in vertigo, motion sickness and vomiting. In: AMA drug evaluations. 4th ed.Chicago: American Medical Association, 1980: 408–29.
13.
Food and Drug Administration Advisory Committee. The Bendectin Peer Group Report. Washington, DC: U.S Department of Health, Education, and Welfare, April 1975: NDA 10–598.
14.
HendersonIWD. Congenital deformities associated with Bendectin. Can Med Assoc J1977; 117: 721–2.
15.
PatersonDC. Congenital deformities. Can Med Assoc J1969; 101: 175–6.
16.
PatersonDC. Congenital deformities associated with Bendectin. Can Med Assoc J1977; 116: 1348.
17.
RothmanKJFylerDCGoldblattAKreidbergMB. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol1979; 109: 433–9.
18.
HarronDWGGriffithsKShanksRG. Debendox and congenital malformations in Northern Ireland. Br Med J1980; 281: 1379–81.
19.
KorcohM. The Bendectin debate. Can Med Assoc J1980; 123: 922–8.
20.
BronsonG. Jury awards damages for birth defects alleged to Richardson-Merrell Inc. Wall Street Journal1980; 60 (Mar 24): 19.
21.
SmithellsRWSheppardS. Teratogenicity testing in humans: a method demonstrating safety of Bendectin. Teratology1978; 17: 31–6.
22.
FDA Drug Bull1981; 11: 1–2.
23.
Bendectin and pyloric stenosis. FDA Drug Bull1983; 13: 14–15.
24.
EskenaziBBrackenMB. Bendectin (Debendox) as a risk factor for pyloric stenosis. Am J Obstet Gynecol1982; 144: 919–24.
